Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

Y Huang, L Zhang, Y Shi, S Ma, M Liao… - Japanese journal of …, 2015 - academic.oup.com
Objective This study is to analyze the data of Chinese subpopulation in the Tarceva Lung
Cancer Survival Treatment Study (TRUST-China) which was a global Phase IV study …
被引用次数：12 相关文章

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.

Y Huang, L Zhang, Y Shi, S Ma, M Liao… - Japanese Journal of …, 2015 - europepmc.org
Objective This study is to analyze the data of Chinese subpopulation in the Tarceva Lung
Cancer Survival Treatment Study (TRUST-China) which was a global Phase IV study …

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

Y Huang, L Zhang, Y Shi, S Ma… - … journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective This study is to analyze the data of Chinese subpopulation in the Tarceva Lung
Cancer Survival Treatment Study (TRUST-China) which was a global Phase IV study …
[PDF] academia.edu

[PDF][PDF] Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

Y Huang, L Zhang, Y Shi, S Ma, M Liao… - Japanese Journal of …, 2015 - academia.edu
Objective: This study is to analyze the data of Chinese subpopulation in the Tarceva Lung
Cancer Survival Treatment Study (TRUST-China) which was a global Phase IV study …
[PDF] psu.edu

[PDF][PDF] Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

Y Huang, L Zhang, Y Shi, S Ma, M Liao, C Bai… - Japanese Journal of …, 2015 - Citeseer
Objective: This study is to analyze the data of Chinese subpopulation in the Tarceva Lung
Cancer Survival Treatment Study (TRUST-China) which was a global Phase IV study …

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.

Y Huang, L Zhang, Y Shi, S Ma, M Liao… - … Journal of Clinical …, 2015 - search.ebscohost.com
Objective: This study is to analyze the data of Chinese subpopulation in the Tarceva Lung
Cancer Survival Treatment Study (TRUST-China) which was a global Phase IV study …
[PDF] psu.edu

[PDF][PDF] Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

Y Huang, L Zhang, Y Shi, S Ma, M Liao, C Bai… - Japanese Journal of …, 2015 - Citeseer
Objective: This study is to analyze the data of Chinese subpopulation in the Tarceva Lung
Cancer Survival Treatment Study (TRUST-China) which was a global Phase IV study …

[引用][C] Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

Y Huang, L Zhang, Y Shi, S Ma… - … journal of clinical …, 2015 - Oxford University Press